Success Stories: EB-1A Approval for a Chinese Bioinformatics Data Analyst Based in Utah
Client’s Testimonial:
“Thank you very much!(…) I have referred 2 of my friends to you and will continue doing so if more friends come to ask me about it.”
On February 22nd, 2019, we received another EB-1A (Alien of Extraordinary Ability) approval for a Bioinformatics Data Analyst in the Field of Bioinformatics (Approval Notice).
General Field: Bioinformatics
Position at the Time of Case Filing: Bioinformatics Data Analyst
Country of Origin: China
State of Residence at the Time of Filing: Utah
Approval Notice Date: February 22nd, 2019
Processing Time: 6 months, 12 days
Case Summary:
A Bioinformatics Data Analyst sought assistance from North America Immigration Law Group (NAILG) to help her with the first step of the green card process: filing an I-140 petition. With extensive research experience and significant contributions made to the field of bioinformatics, our client was a suitable candidate for EB-1A (Alien of Extraordinary Ability), the most stringent immigrant-visa category. After assessing her credentials, we were confident that we could successfully obtain EB-1A approval and we worked diligently to prove the value of her work to the United States.
One of many significant research projects of our client is the development of a pipeline to identify novel drugs for chronic pain treatment, which has impacted the medical industry regarding the improvement of chronic pain management. At the time of filing, our client’s work had garnered 337 citations and she had an impressive publication record of 9 peer-reviewed scientific articles. Moreover, she had conducted reviews for 20 papers in highly acclaimed journals. These achievements reflect our client’s exceptional performance in the field of bioinformatics.
The 5 recommendation letters our client collected from other renowned experts were incorporated into her petition packet to further strengthen her case. The words contributed by an independent recommender read: “It is estimated that 10% of the population suffers from chronic neuropathic pain, and [client]’s breakthrough is revolutionizing drug research and treatment options for this condition. This is just one of the many kinds of disorders for which [client]’s breakthrough is helping to develop treatments. The importance of [client]’s contributions in this area is hard to overstate”. These letters proved beyond doubt that our client is an expert in her field and that her substantial contributions make her an asset to the US scientific community.
In addition to carefully assembling the required documents to file the EB1A petition on behalf of our client, our legal team has also included customized figures and tables to compare her citation and publication records with her peers. The visual presentation of the data has indeed further constructed and supported the arguments in the petition. We congratulate our client on her EB1A success and wish her the very best as she continues to progress the field of bioinformatics in the US.